Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2014) 35 P921 | DOI: 10.1530/endoabs.35.P921

1”C. I. Parhon’ National Institute of Endocrinology, Bucharest, Romania; 2Carol Davila’ University of Medicine and Pharmacy, Bucharest, Romania.

Background: Acromegaly is associated with increased prevalence of thyroid diseases, particularly of differentiated thyroid carcinoma.

Aim: To assess prevalence of thyroid diseases and thyroid cancer in patients with acromegaly.

Patients and methods: Forty (10 M/30 F) acromegalic patients, 14 residents in iodine deficient areas, aged 47±12.8 years, were retrospectively reviewed. Mean duration of acromegaly was 7.6±9.5 years and median post diagnosis follow-up was 4.1 years. GH, IGF1 were measured by chemiluminescence (Liaison), TSH, FT4 by immunometric assays (Immulite). Thyroid ultrasonography was performed in all cases, thyroid scintigraphy was performed when indicated; fine needle aspiration biopsy (FNAB) was performed in suspicious nodules, according to current guidelines.

Results: Thyroid abnormalities were present in 28 patients (70%) in our series: diffuse goiter in 8 patients (20%), simple nodular goiter in 5 patients (12.5%), nontoxic multinodular goiter in 10 patients (25%), toxic multinodular goiter in 4 patients (10%), Graves’ disease in one patient (2.5%); thyroid carcinoma was found in 3 patients (7.5%). Patients with thyroid nodules larger than 1 cm had significant longer acromegaly duration (6.1±3.6 years) than patients without nodules or nodules less than 1 cm (2.1±1.5 years), P=0.008. Histological type in patients with thyroid carcinoma was follicular variant of papillary thyroid carcinoma in all three cases: 2 microcarcinomas and one macrocarcinoma. All three thyroid carcinomas patients underwent total thyroidectomy and radioiodine treatment (mean cumulative dose 181.7 mCi 131I) and were in stable remission.

Conclusion: Due to increased prevalence of differentiated thyroid carcinoma, active screening for thyroid abnormalities is mandatory both in iodine sufficient and deficient areas, especially in patients with longer duration of acromegaly.

Article tools

My recent searches

No recent searches.